Unnamed stage
$2.7m
Tessara Therapeutics Raises $2.7 Million to Develop Mimetic Brain Tissue
Tessara Therapeutics closed a $2.7 million oversubscribed Round 1 raise led by a New South Wales syndicate, appointed Phillip Smith to its board, and works with CSIRO and Bio-Link Australia.